Sandra Patterson - Mar 10, 2023 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role
SVP, Controllership
Signature
/s/ Amy Kim by Power of Attorney for Sandra C. Patterson
Stock symbol
GILD
Transactions as of
Mar 10, 2023
Transactions value $
-$63,680
Form type
4
Date filed
3/13/2023, 09:04 PM
Previous filing
Mar 9, 2023
Next filing
Jun 12, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GILD Common Stock Options Exercise +1.6K +6.65% 25.7K Mar 10, 2023 Direct F1
transaction GILD Common Stock Options Exercise +1.32K +5.14% 27K Mar 10, 2023 Direct F1
transaction GILD Common Stock Tax liability -$63.7K -801 -2.97% $79.50 26.2K Mar 10, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GILD Restricted Stock Unit Options Exercise -1.6K -8.27% 17.7K Mar 10, 2023 Common Stock 1.6K Direct F1, F2
transaction GILD Restricted Stock Unit Options Exercise -1.32K -7.44% 16.4K Mar 10, 2023 Common Stock 1.32K Direct F1, F3
transaction GILD Restricted Stock Unit Award +6.13K +37.31% 22.6K Mar 10, 2023 Common Stock 6.13K Direct F1, F3
transaction GILD Non-qualified Stock Option (Right to Buy) Award $0 +10.4K $0.00 10.4K Mar 10, 2023 Common Stock 10.4K $79.50 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2 The restricted stock units have a four year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested.
F3 The restricted stock units have a four year vesting schedule. 25% vest on the first anniversary of the date of grant. The balance will vest 6.25% quarterly thereafter until fully vested.
F4 The shares subject to the option have a four year vesting schedule. 25% vest on the first anniversary of the date of grant. The balance will vest 6.25% quarterly thereafter until fully vested.